Description: The global Microbiome Therapeutics Market is projected to grow from USD 339.8 million in 2026 to USD 4,987.2 million by 2035, expanding at a strong 34.8% CAGR. Growth is driven by advances in microbiome research, genomics, live biotherapeutic products, personalized medicine, rising chronic disease prevalence, gut microbiome therapies, and increasing applications across gastrointestinal disorders, oncology, metabolic, and neurological conditions.
Category: Search Engine Optimization
Tag: #MicrobiomeTherapeutics, #Microbiome, #GutMicrobiome, #LiveBiotherapeutics, #LBPs, #MicrobiomeDrugs, #PrecisionMedicine, #PersonalizedMedicine, #GutHealth, #Biotechnology, #Pharmaceuticals,